UNICHEM LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of UNICHEM LABORATORIES have increased by 5.76% YoY .
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
UNICHEM LABORATORIES Last 5 Annual Financial Results
[BOM: 506690|NSE : UNICHEMLAB]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹1,343 Cr | ₹1,270 Cr | ₹1,235 Cr | ₹1,104 Cr | ₹1,180 Cr |
| Expenses | ₹1,389 Cr | ₹1,197 Cr | ₹1,144 Cr | ₹1,155 Cr | ₹1,264 Cr |
| Operating Profit (Excl OI) | ₹-46 Cr | ₹73 Cr | ₹91 Cr | ₹-51 Cr | ₹-83 Cr |
| Other Income | ₹39 Cr | ₹48 Cr | ₹50 Cr | ₹91 Cr | ₹98 Cr |
| Interest | ₹17 Cr | ₹6.11 Cr | ₹5.12 Cr | ₹7.85 Cr | ₹7.52 Cr |
| Depreciation | ₹113 Cr | ₹91 Cr | ₹84 Cr | ₹82 Cr | ₹67 Cr |
| Profit Before Tax | ₹-176 Cr | ₹22 Cr | ₹51 Cr | ₹-48 Cr | ₹-60 Cr |
| Profit After Tax | ₹-202 Cr | ₹33 Cr | ₹34 Cr | ₹-60 Cr | ₹-26 Cr |
| Consolidated Net Profit | ₹-202 Cr | ₹33 Cr | ₹34 Cr | ₹-60 Cr | ₹-24 Cr |
| Earnings Per Share (Rs) | ₹-10.01 | ₹-28.72 | ₹4.70 | ₹4.88 | ₹-8.55 |
| PAT Margin (%) | -4.13 | -15.06 | 2.60 | 2.78 | -5.45 |
| ROE(%) | -2.95 | -8.04 | 1.28 | 1.35 | -2.34 |
| ROCE(%) | -1.47 | -5.60 | 1.00 | 2.11 | -1.46 |
| Total Debt/Equity(x) | 0.09 | 0.12 | 0.13 | 0.04 | 0.07 |
Key Financials |
||
| Market Cap | : | ₹ 5,056.1 Cr |
| Revenue (TTM) | : | ₹ 1,774.7 Cr |
| Net Profit(TTM) | : | ₹ -5.6 Cr |
| EPS (TTM) | : | ₹ -0.8 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| UNICHEM LABORATORIES | -10.1% | -16.5% | 78.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
| CIPLA | 1.7% | 0.5% | 23.7% |
| DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
| ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
| DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
| MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
| TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
| LUPIN | 4.1% | 5.1% | 71.7% |
UNICHEM LABORATORIES Revenues
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | 5.76 % |
| 5 Yr CAGR | 3.29 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,343 Cr | 5.76 | |
| Mar2023 | ₹1,270 Cr | 2.81 | |
| Mar2022 | ₹1,235 Cr | 11.91 | |
| Mar2021 | ₹1,104 Cr | -6.47 | |
| Mar2020 | ₹1,180 Cr | - | |
UNICHEM LABORATORIES Operating Profit
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹-46 Cr | Negative | |
| Mar2023 | ₹73 Cr | -20.10 | |
| Mar2022 | ₹91 Cr | Positive | |
| Mar2021 | ₹-51 Cr | Negative | |
| Mar2020 | ₹-83 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | -3.39% | Negative | |
| Mar2023 | 5.73% | -22.36 | |
| Mar2022 | 7.38% | Positive | |
| Mar2021 | -4.6% | Negative | |
| Mar2020 | -7.08% | - | |
UNICHEM LABORATORIES Profit After Tax
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-202 Cr | Negative | |
| Mar2023 | ₹33 Cr | -3.68 | |
| Mar2022 | ₹34 Cr | Positive | |
| Mar2021 | ₹-60 Cr | Negative | |
| Mar2020 | ₹-24 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -4.13 % | Negative | |
| Mar2023 | -15.06 % | Negative | |
| Mar2022 | 2.6 % | -6.47 | |
| Mar2021 | 2.78 % | Positive | |
| Mar2020 | -5.45 % | - | |
UNICHEM LABORATORIES Earnings Per Share (EPS)
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹-10 | Negative | |
| Mar2023 | ₹-29 | Negative | |
| Mar2022 | ₹4.70 | -3.69 | |
| Mar2021 | ₹4.88 | Positive | |
| Mar2020 | ₹-8.55 | - | |
UNICHEM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | -1.47% | Negative | |
| Mar2023 | -5.6% | Negative | |
| Mar2022 | 1% | -52.61 | |
| Mar2021 | 2.11% | Positive | |
| Mar2020 | -1.46% | - | |
UNICHEM LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹718.2 |
| Current MarketCap | : | ₹ 5,056.1 Cr |
| Updated EOD on | : | Dec 20,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -10.1% |
-16.5% |
78.1% |
| SENSEX | -5% |
0.6% |
9.2% |
UNICHEM LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 0.1% | 4% | 45% |
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
| S&P BSE SMALL CAP | -3.2% | 5.1% | 31.1% |
| S&P BSE MIDSMALLCAP | -3.2% | 4.4% | 29.5% |
No NSE index found
You may also like the below Video Courses
FAQ about UNICHEM LABORATORIES Financials
How the annual revenues of UNICHEM LABORATORIES have changed ?
The Revenues of UNICHEM LABORATORIES have increased by 5.76% YoY .
How the Earnings per Share (EPS) of UNICHEM LABORATORIES have changed?
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has decreased by Negative YoY .
Check out Intrinsic Value of Peers of UNICHEM LABORATORIES
Compare Stock Analytics of Peers of UNICHEM LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
